IRIS
CANONICA, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.228
AS - Asia 4.235
EU - Europa 3.663
SA - Sud America 1.534
AF - Africa 688
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 14
Totale 25.384
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.959
SG - Singapore 2.340
BR - Brasile 1.415
CN - Cina 1.075
FI - Finlandia 969
IE - Irlanda 833
NG - Nigeria 599
FR - Francia 419
DE - Germania 396
NL - Olanda 264
GB - Regno Unito 242
TR - Turchia 212
CA - Canada 205
IT - Italia 153
SE - Svezia 102
RU - Federazione Russa 100
IN - India 84
IL - Israele 83
HK - Hong Kong 60
BD - Bangladesh 57
IQ - Iraq 48
MX - Messico 38
UA - Ucraina 36
AR - Argentina 33
VN - Vietnam 31
SA - Arabia Saudita 29
ZA - Sudafrica 28
BE - Belgio 25
ES - Italia 24
PK - Pakistan 24
KR - Corea 23
UZ - Uzbekistan 22
EC - Ecuador 21
JP - Giappone 18
IR - Iran 17
AU - Australia 16
CZ - Repubblica Ceca 16
CO - Colombia 15
VE - Venezuela 14
AE - Emirati Arabi Uniti 12
AT - Austria 12
CL - Cile 12
KE - Kenya 12
NP - Nepal 12
PL - Polonia 12
RO - Romania 12
EG - Egitto 11
ID - Indonesia 11
AZ - Azerbaigian 10
DZ - Algeria 9
JO - Giordania 9
MA - Marocco 9
A2 - ???statistics.table.value.countryCode.A2??? 8
OM - Oman 8
UY - Uruguay 8
GE - Georgia 7
KG - Kirghizistan 7
DK - Danimarca 6
GR - Grecia 6
PT - Portogallo 6
NO - Norvegia 5
PA - Panama 5
PE - Perù 5
PH - Filippine 5
PY - Paraguay 5
TN - Tunisia 5
TW - Taiwan 5
BO - Bolivia 4
CH - Svizzera 4
ET - Etiopia 4
EU - Europa 4
MD - Moldavia 4
MN - Mongolia 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
LB - Libano 3
MY - Malesia 3
PS - Palestinian Territory 3
RS - Serbia 3
AL - Albania 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GA - Gabon 2
GT - Guatemala 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LT - Lituania 2
MT - Malta 2
PR - Porto Rico 2
SN - Senegal 2
TV - Tuvalu 2
AM - Armenia 1
Totale 25.369
Salva come PNG Salva come JPEG
Città #
Wilmington 4.542
San Mateo 1.699
The Dalles 1.489
Singapore 1.286
Ann Arbor 1.032
Shanghai 1.003
Helsinki 966
Leawood 869
Dublin 830
Lawrence 773
Princeton 773
Benin City 596
Fairfield 577
Woodbridge 513
Chandler 488
Paris 391
Amsterdam 238
London 174
Kocaeli 169
Toronto 160
Ashburn 148
New York 123
São Paulo 111
Boardman 109
Norwalk 96
Santa Clara 74
Hong Kong 49
Monmouth Junction 43
Belo Horizonte 42
Los Angeles 42
Rio de Janeiro 37
Moscow 34
Seattle 33
Falkenstein 32
Phoenix 31
Curitiba 27
Milan 27
Des Moines 24
Campinas 21
Dhaka 21
Tashkent 21
Brasília 20
Brussels 20
Reston 20
Beijing 19
Guarulhos 19
Porto Alegre 19
Redmond 19
Redwood City 18
San Diego 18
Baghdad 17
Cambridge 14
Clearwater 14
Mumbai 13
Munich 13
Abbiategrasso 12
Andover 12
Goiânia 12
Houston 12
Brooklyn 11
Calgary 11
Council Bluffs 11
Frankfurt am Main 11
Istanbul 11
Riyadh 11
São Bernardo do Campo 11
Chicago 10
Columbus 10
Falls Church 10
Guayaquil 10
Hanoi 10
Kathmandu 10
Ribeirão Preto 10
Baku 9
Brno 9
Buffalo 9
Contagem 9
Dallas 9
Florianópolis 9
Hanover 9
Jeddah 9
Joinville 9
Juiz de Fora 9
Piracicaba 9
Pune 9
Rome 9
Sorocaba 9
Amman 8
Augusta 8
Fortaleza 8
Jakarta 8
Johannesburg 8
Lahore 8
Londrina 8
Meppel 8
Muscat 8
Nairobi 8
Naples 8
Recife 8
São José dos Pinhais 8
Totale 20.381
Salva come PNG Salva come JPEG
Nome #
Quality of life and polysensitization in young men with intermittent asthma 185
100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco 121
Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab 107
A critical appraisal on AIT in childhood asthma. 106
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry 102
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: an Italian Multicenter Study. 92
Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients. 90
An academic allergy unit during COVID-19 pandemic in Italy. 88
Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis--a randomized controlled study 85
Comparison of the colony forming capacities of human T lymphocyte subpopulations 77
A Charter to Improve Patient Care in Severe Asthma 75
Evolving phenotypes to endotypes: is precision medicine achievable in asthma? 74
60Co therapy as an "allergic breakthrough" in a case of food allergy 72
30 Years Of Sublingual Immunotherapy 72
2019 ARIA Care pathways for allergen immunotherapy 69
Strategies to reduce corticosteroid-related adverse events in asthma 67
Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing 67
A multi-allergen ELISA screening method. Comparison with Pharmacia CAP system and Phazet skin prick test 66
Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps 64
A 4-year trial of tiotropium in chronic obstructive pulmonary disease 64
The Severe Asthma Network in Italy: Findings and Perspectives 63
A model of allergen-driven human airway contraction:beta2 pathway dysfunction without cytokine involvement 63
A new protocol for specific oral tolerance induction in children with IgE-mediated cow's milk allergy 63
A survey of the burden of allergic rhinitis in Europe 63
Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment 62
Turkish Version of the Chronic Urticaria Quality of Life Questionnaire: Cultural Adaptation, Assessment of Reliability and Validity 62
Microarray Immunodiagnostics for Aeroallergens 60
A multicentric study on sensitivity and specificity of a new in vitro test for measurement of IgE antibodies 60
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis 60
A double-blind, placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjects 60
Real-life studies of biologics used in asthma patients: key differences and similarities to trials 59
Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis 59
Escaping the trap of allergic rhinitis. 58
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients 58
360 degree perspective on allergic rhinitis management in Italy: A survey of GPs, pharmacists and patients 58
Appropriateness in allergic respiratory diseases health care in Italy: definitions and organizational aspects 57
A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL) 57
Pharmacoeconomic evaluation of oral corticosteroid adverse events in patients with severe asthma 57
Treatable traits in chronic rhinosinusitis with nasal polyps 57
EAACI guidelines on allergen immunotherapy: Executive statement 55
A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress 55
[GA(2)LEN (Global Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases] 55
Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study 54
Choosing wisely in Allergology: a Slow Medicine approach to the discipline promoted by the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) 54
Asthma: personalized and precision medicine 52
Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA) 52
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials 52
Inhaled corticosteroids safety and adverse effects in patients with asthma 51
EUFOREA consensus on biologics for CRSwNP with or without asthma 51
A Review of the Evidence from Comparative Studies of Levocetirizine and Desloratadine for the Symptoms of Allergic Rhinitis 51
Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions 51
[Our experience in the treatment of bronchial asthma and asthmatic bronchitis with salbutamol] 51
Clinical outcomes related to molecular allergy diagnosis 50
Current insights in allergen immunotherapy. 50
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly. 50
Suppressor activity of T cells bearing Fc-receptors for IgG on lymphoid colony formation 50
A review of the use of fluticasone furoate since its launch 50
Pilot study of mobile phone technology in allergic rhinitis in European countries: The MASK-rhinitis study 50
EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria 49
GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe 49
Year in review: Allergen immunotherapy 49
The EAACI/GA²LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update 48
A role for the intranasal formulation of azelastine hydrochloride/fluticasone propionate in the treatment of allergic rhinitis 48
New drugs in early-stage clinical trials for allergic rhinitis 47
World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics 47
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update 47
GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe 47
[ICAM-1 and allergic inflammation] 47
La diagnostica delle malattie autoimmuni 47
GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic' 46
A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients 46
Ketotifen treatment of adverse reactions to foods: clinical and immunological effects 46
A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire 46
Characteristics and treatment regimens across ERS SHARP severe asthma registries. 45
EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy 45
Assessing biomarkers in a real-world severe asthma study (ARIETTA) 45
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper 44
Abnormalities of immunocompetent cells in primary biliary cirrhosis 44
T cell activation surface markers and autologous mixed lymphocyte reaction do not differ in true and pseudo food allergy 43
Imbalance of circulating T lymphocytes subsets in allergic ophtalmorhinitis 43
Wellbeing, illness perception and coping strategies in Italian celiac patients 43
EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria 43
[Anti-leukotriene agents: rationale for and prospects of use] 43
Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria. 42
Abnormalities of circulating T cell subsets in atopy: influence of specific immunotherapy 42
Performance evaluation of ImmunoCAP® ISAC 112: a multi-site study 42
Circulating T lymphocytes in Hashimoto's disease: imbalance of subsets and presence of activated cells 42
Responders and nonresponders to pharmacotherapy and allergen immunotherapy 42
Rhinitis and asthma in athletes: an ARIA document in collaboration with GALEN 42
Quality-of-life issues in survivors to anaphylactic reactions to drugs 42
The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey 42
Update on latin American chronic urticaria registry (CUR) 41
Atopic asthma: evaluation of T-cell activation by means of 4F2 monoclonal antibody 41
The adhesion molecules of allergic inflammation: recent insights into their functional roles 41
Serious Asthma Events with Budesonide plus Formoterol vs. Budesonide Alone 41
T cell activation through different membrane structures (T3/Ti, T11, T44) and frequency analysis of proliferating and interleukin-2 producer T lymphocyte precursors in aged individuals 41
EAACI/GA2LEN/EDF guideline: management of urticaria 41
Inhibition of autologous mixed lymphocyte reaction by aggregated IgG molecules 41
The North-Western Italian experience with anti IL-5 therapy amd comparison with regulatory trials. 40
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs 40
Totale 5.713
Salva come PNG Salva come JPEG
Categoria #
all - tutte 282.305
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 282.305
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218.207 11 32 11 12 18 2.500 1.316 572 2.071 696 14 954
2021/20223.078 117 7 51 783 15 17 131 612 304 295 682 64
2022/20234.270 1.621 85 827 139 101 86 19 93 282 776 219 22
2023/20243.405 169 387 772 31 32 141 119 117 51 34 640 912
2024/20255.989 79 34 38 53 56 788 212 382 704 1.956 749 938
2025/2026612 612 0 0 0 0 0 0 0 0 0 0 0
Totale 26.328